Landmark Court Ruling In UK Could Pave Way For Cheaper, Generic PrEP
September 20, 2018 /
Photo courtesy of BigStock/Mbruxelle
Photo courtesy of BigStock/Mbruxelle
GayStarNews reports that Britain’s High Court today ruled to overturn pharmaceutical company Gilead Science’s patent extension on Truvada, the HIV medication also used for PrEP (Pre-Exposure Prophylaxis) which, when taken as advised, stops HIV negative people acquiring HIV.
